miR-223, which was shown to be upregulated in pancreatic cancer and inhibits ZIC1 mRNA via PI3K/Akt/mTOR signaling pathway, is associated with poor survival [251]. The gene discussed is AKT1; the disease is pancreatic neoplasm.